353 related articles for article (PubMed ID: 28253484)
1. Identification of fragile X pre-mutation carriers in the Chinese obstetric population using a robust FMR1 polymerase chain reaction assay: implications for screening and prenatal diagnosis.
Cheng YK; Lin CS; Kwok YK; Chan YM; Lau TK; Leung TY; Choy KW
Hong Kong Med J; 2017 Apr; 23(2):110-6. PubMed ID: 28253484
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and instability of fragile X alleles: implications for offering fragile X prenatal diagnosis.
Cronister A; Teicher J; Rohlfs EM; Donnenfeld A; Hallam S
Obstet Gynecol; 2008 Mar; 111(3):596-601. PubMed ID: 18310361
[TBL] [Abstract][Full Text] [Related]
3. Fragile X analysis of 1112 prenatal samples from 1991 to 2010.
Nolin SL; Glicksman A; Ding X; Ersalesi N; Brown WT; Sherman SL; Dobkin C
Prenat Diagn; 2011 Oct; 31(10):925-31. PubMed ID: 21717484
[TBL] [Abstract][Full Text] [Related]
4. An assessment of screening strategies for fragile X syndrome in the UK.
Pembrey ME; Barnicoat AJ; Carmichael B; Bobrow M; Turner G
Health Technol Assess; 2001; 5(7):1-95. PubMed ID: 11262423
[TBL] [Abstract][Full Text] [Related]
5. Fragile-X carrier screening and the prevalence of premutation and full-mutation carriers in Israel.
Toledano-Alhadef H; Basel-Vanagaite L; Magal N; Davidov B; Ehrlich S; Drasinover V; Taub E; Halpern GJ; Ginott N; Shohat M
Am J Hum Genet; 2001 Aug; 69(2):351-60. PubMed ID: 11443541
[TBL] [Abstract][Full Text] [Related]
6. Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test.
Brown WT; Houck GE; Jeziorowska A; Levinson FN; Ding X; Dobkin C; Zhong N; Henderson J; Brooks SS; Jenkins EC
JAMA; 1993 Oct; 270(13):1569-75. PubMed ID: 8371467
[TBL] [Abstract][Full Text] [Related]
7. Qualitative assessment of FMR1 (CGG)n triplet repeat status in normal, intermediate, premutation, full mutation, and mosaic carriers in both sexes: implications for fragile X syndrome carrier and newborn screening.
Hantash FM; Goos DG; Tsao D; Quan F; Buller-Burckle A; Peng M; Jarvis M; Sun W; Strom CM
Genet Med; 2010 Mar; 12(3):162-73. PubMed ID: 20168238
[TBL] [Abstract][Full Text] [Related]
8. [Results of carrier screening and prenatal diagnosis for FMR1 gene in 819 cases].
Li J; Du J; Yang Q; Xu J; Li M; Fu H; Li M
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Oct; 37(10):1104-1107. PubMed ID: 32924111
[TBL] [Abstract][Full Text] [Related]
9. A 15-year-long Southern blotting analysis of FMR1 to detect female carriers and for prenatal diagnosis of fragile X syndrome in Taiwan.
Tzeng CC; Tsai LP; Chang YK; Hung YJ; Chang YY; Su YP; Jiang JJ; Liang HM
Clin Genet; 2017 Aug; 92(2):217-220. PubMed ID: 28139839
[TBL] [Abstract][Full Text] [Related]
10. Fragile X syndrome screening in pregnant women and women planning pregnancy shows a remarkably high FMR1 premutation prevalence in the Balearic Islands.
Alfaro Arenas R; Rosell Andreo J; Heine Suñer D;
Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1023-1031. PubMed ID: 27333191
[TBL] [Abstract][Full Text] [Related]
11. Prenatal diagnosis and carrier screening for fragile X by PCR.
Brown WT; Nolin S; Houck G; Ding X; Glicksman A; Li SY; Stark-Houck S; Brophy P; Duncan C; Dobkin C; Jenkins E
Am J Med Genet; 1996 Jul; 64(1):191-5. PubMed ID: 8826474
[TBL] [Abstract][Full Text] [Related]
12. The risk of fragile X premutation expansion is lower in carriers detected by general prenatal screening than in carriers from known fragile X families.
Geva E; Yaron Y; Shomrat R; Ben-Yehuda A; Zabari S; Peretz H; Naiman T; Yeger H; Orr-Urtreger A
Genet Test; 2000; 4(3):289-92. PubMed ID: 11142761
[TBL] [Abstract][Full Text] [Related]
13. Pilot fragile X screening in normal population of Taiwan.
Tzeng CC; Cho WC; Kuo PL; Chen RM
Diagn Mol Pathol; 1999 Sep; 8(3):152-6. PubMed ID: 10565687
[TBL] [Abstract][Full Text] [Related]
14. Molecular predictors of cognitive involvement in female carriers of fragile X syndrome.
Taylor AK; Safanda JF; Fall MZ; Quince C; Lang KA; Hull CE; Carpenter I; Staley LW; Hagerman RJ
JAMA; 1994 Feb; 271(7):507-14. PubMed ID: 8301764
[TBL] [Abstract][Full Text] [Related]
15. Analysis of FMR1 gene expression in female premutation carriers using robust segmented linear regression models.
García-Alegría E; Ibáñez B; Mínguez M; Poch M; Valiente A; Sanz-Parra A; Martinez-Bouzas C; Beristain E; Tejada MI
RNA; 2007 May; 13(5):756-62. PubMed ID: 17449730
[TBL] [Abstract][Full Text] [Related]
16. FMR1 CGG repeat expansion mutation detection and linked haplotype analysis for reliable and accurate preimplantation genetic diagnosis of fragile X syndrome.
Rajan-Babu IS; Lian M; Cheah FSH; Chen M; Tan ASC; Prasath EB; Loh SF; Chong SS
Expert Rev Mol Med; 2017 Jul; 19():e10. PubMed ID: 28720156
[TBL] [Abstract][Full Text] [Related]
17. Screening for the presence of FMR1 premutation alleles in women with parkinsonism.
Cilia R; Kraff J; Canesi M; Pezzoli G; Goldwurm S; Amiri K; Tang HT; Pan R; Hagerman PJ; Tassone F
Arch Neurol; 2009 Feb; 66(2):244-9. PubMed ID: 19204162
[TBL] [Abstract][Full Text] [Related]
18. A Robust Polymerase Chain Reaction-based Assay for Quantifying Cytosine-guanine-guanine Trinucleotide Repeats in Fragile X Mental Retardation-1 Gene.
Wang H; Zhu X; Gui B; Cheung WC; Shi M; Yang Z; Kwok KY; Lim R; Pietilä S; Zhu Y; Choy KW
J Vis Exp; 2019 Sep; (151):. PubMed ID: 31566610
[TBL] [Abstract][Full Text] [Related]
19. Preimplantation genetic diagnosis versus prenatal diagnosis-decision-making among pregnant FMR1 premutation carriers.
Haham LM; Avrahami I; Domniz N; Ries-Levavi L; Berkenstadt M; Orvieto R; Cohen Y; Elizur SE
J Assist Reprod Genet; 2018 Nov; 35(11):2071-2075. PubMed ID: 30136016
[TBL] [Abstract][Full Text] [Related]
20. Prenatal carrier testing for fragile X: counseling issues and challenges.
Musci TJ; Moyer K
Obstet Gynecol Clin North Am; 2010 Mar; 37(1):61-70, Table of Contents. PubMed ID: 20494258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
